{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:44:38Z","timestamp":1779317078385,"version":"3.51.4"},"reference-count":147,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009318","name":"Helmholtz Association","doi-asserted-by":"publisher","award":["KA1-Co-02 \u201cCOVIPA\u201d"],"award-info":[{"award-number":["KA1-Co-02 \u201cCOVIPA\u201d"]}],"id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["256073931"],"award-info":[{"award-number":["256073931"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["272983813"],"award-info":[{"award-number":["272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["413517907"],"award-info":[{"award-number":["413517907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2023,5,24]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>SARS-CoV-2 infection may affect the liver in healthy individuals but also influences the course of COVID-19 in patients with chronic liver disease (CLD). As described in healthy individuals, a strong SARS-CoV-2-specific adaptive immune response is important for the outcome of COVID-19, however, knowledge on the adaptive immune response in CLD is limited.<\/jats:p>\n                  <jats:p>Here, we review the clinical and immunological features of SARS-CoV-2 infection in individuals with CLD. Acute liver injury occurs in many cases of SARS-CoV-2 infection and may be induced by multiple factors, such as cytokines, direct viral infection or toxic effects of COVID-19 drugs. In individuals with CLD, SARS-CoV-2 infection may have a more severe course and promote decompensation and particularly in patients with cirrhosis. Compared with healthy individuals, the SARS-CoV-2-specific adaptive immune responses is impaired in patients with CLD after both, natural infection and vaccination but improves at least partially after booster vaccination.<\/jats:p>\n                  <jats:p>Following SARS-CoV-2 vaccination, rare cases of acute vaccine-induced liver injury and the development of autoimmune-like hepatitis have been reported. However, the concomitant elevation of liver enzymes is reversible under steroid treatment.<\/jats:p>","DOI":"10.1136\/gutjnl-2023-329623","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T13:20:23Z","timestamp":1686748823000},"page":"1783-1794","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease"],"prefix":"10.1136","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-8620","authenticated-orcid":false,"given":"Hendrik","family":"Luxenburger","sequence":"first","affiliation":[{"name":"Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-4135","authenticated-orcid":false,"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[{"name":"Department of Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"2025112109554130000_72.9.1783.1","unstructured":"WHO . Coronavirus (COVID-19) dashboard. Available: https:\/\/covid19.who.int [Accessed 5 Mar 2023]."},{"key":"2025112109554130000_72.9.1783.2","unstructured":"CDC . Cases, data, and surveillance. centers for disease control and prevention. 2020. Available: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/cases-updates\/burden.html [Accessed 16 Jan 2023]."},{"key":"2025112109554130000_72.9.1783.3","doi-asserted-by":"publisher","DOI":"10.1056\/nejmcp2009575"},{"key":"2025112109554130000_72.9.1783.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp2009249"},{"key":"2025112109554130000_72.9.1783.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2025112109554130000_72.9.1783.6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"key":"2025112109554130000_72.9.1783.7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(21)00432-3","article-title":"Single-dose administration and the influence of the timing of the booster dose on Immunogenicity and efficacy of Chadox1 nCoV-19 (Azd1222) vaccine: a pooled analysis of four randomised trials","volume":"397","author":"Voysey","year":"2021","journal-title":"The Lancet"},{"key":"2025112109554130000_72.9.1783.8","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of Cd8+ T cells by SARS-Cov-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"key":"2025112109554130000_72.9.1783.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32324-x","article-title":"COVID-19 mRNA booster vaccine induces transient Cd8+ T Effector cell responses while conserving the memory pool for subsequent reactivation","volume":"13","author":"Reinscheid","year":"2022","journal-title":"Nat Commun"},{"key":"2025112109554130000_72.9.1783.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.063"},{"key":"2025112109554130000_72.9.1783.11","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.immuni.2021.05.010","article-title":"Longitudinal analysis reveals that delayed bystander Cd8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease","volume":"54","author":"Bergamaschi","year":"2021","journal-title":"Immunity"},{"key":"2025112109554130000_72.9.1783.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.002"},{"key":"2025112109554130000_72.9.1783.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"2025112109554130000_72.9.1783.14","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14449"},{"key":"2025112109554130000_72.9.1783.15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025112109554130000_72.9.1783.16","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14730"},{"key":"2025112109554130000_72.9.1783.17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4254\/wjh.v14.i11.1953","article-title":"Liver test abnormalities in asymptomatic and mild COVID-19 patients and their association with viral shedding time","volume":"14","author":"Yu","year":"2022","journal-title":"World J Hepatol"},{"key":"2025112109554130000_72.9.1783.18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025112109554130000_72.9.1783.19","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/liv.14601","article-title":"Liver Histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations","volume":"40","author":"Sonzogni","year":"2020","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.20","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9060430","article-title":"SARS-Cov-2 infection and the liver","volume":"9","author":"Morgan","year":"2020","journal-title":"Pathogens"},{"key":"2025112109554130000_72.9.1783.21","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","article-title":"COVID-19 and the liver","volume":"73","author":"Jothimani","year":"2020","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.22","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570"},{"key":"2025112109554130000_72.9.1783.23","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jceh.2020.05.006","article-title":"Pathogenesis of liver injury in Coronavirus disease 2019","volume":"10","author":"Kumar","year":"2020","journal-title":"Journal of Clinical and Experimental Hepatology"},{"key":"2025112109554130000_72.9.1783.24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20111"},{"key":"2025112109554130000_72.9.1783.25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20069"},{"key":"2025112109554130000_72.9.1783.26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s42255-022-00552-6","article-title":"Molecular consequences of SARS-Cov-2 liver Tropism","volume":"4","author":"Wanner","year":"2022","journal-title":"Nat Metab"},{"key":"2025112109554130000_72.9.1783.27","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/ajcp\/aqab009","article-title":"Liver Pathology and SARS-Cov-2 detection in formalin-fixed tissue of patients with COVID-19","volume":"155","author":"Chornenkyy","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"2025112109554130000_72.9.1783.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-020-00649-x"},{"key":"2025112109554130000_72.9.1783.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.002"},{"key":"2025112109554130000_72.9.1783.30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4269\/ajtmh.21-1240","article-title":"Involvement of the liver in COVID-19: A systematic review","volume":"106","author":"Kariyawasam","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"2025112109554130000_72.9.1783.31","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27282"},{"key":"2025112109554130000_72.9.1783.32","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001563"},{"key":"2025112109554130000_72.9.1783.33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141706"},{"key":"2025112109554130000_72.9.1783.34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-Cov-2 infection by reducing Ace2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"key":"2025112109554130000_72.9.1783.35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/1751-2980.12951","article-title":"Severe acute respiratory syndrome Coronavirus-2 infection and the gut\u2013liver axis","volume":"21","author":"Mohandas","year":"2020","journal-title":"J Dig Dis"},{"issue":"1S Suppl 1","key":"2025112109554130000_72.9.1783.36","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/MEG.0000000000002034","article-title":"Cytokine-induced liver injury in Coronavirus Disease-2019 (COVID-19): Untangling the knots","volume":"33","author":"Anirvan","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025112109554130000_72.9.1783.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0146736(20)30183-5"},{"key":"2025112109554130000_72.9.1783.38","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2031994"},{"key":"2025112109554130000_72.9.1783.39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jhep.2022.07.008","article-title":"Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper","volume":"77","author":"Marjot","year":"2022","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12072-020-10077-3","article-title":"Liver injury in Remdesivir-treated COVID-19 patients","volume":"14","author":"Zampino","year":"2020","journal-title":"Hepatol Int"},{"key":"2025112109554130000_72.9.1783.41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.gastro.2022.09.008","article-title":"Minimal risk of drug-induced liver injury with Molnupiravir and Ritonavir-boosted Nirmatrelvir","volume":"164","author":"Wong","year":"2023","journal-title":"Gastroenterology"},{"key":"2025112109554130000_72.9.1783.42","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"2025112109554130000_72.9.1783.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.010"},{"key":"2025112109554130000_72.9.1783.44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.06.019"},{"key":"2025112109554130000_72.9.1783.45","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10072-8"},{"key":"2025112109554130000_72.9.1783.46","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322118"},{"key":"2025112109554130000_72.9.1783.47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2020.06.001","article-title":"High rates of 30-day mortality in patients with cirrhosis and COVID-19","volume":"73","author":"Iavarone","year":"2020","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-Cov-2 infection in patients with chronic liver disease: an international Registry study","volume":"74","author":"Marjot","year":"2021","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.49","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/hep.32780","article-title":"Breakthrough SARS-Cov-2 infection outcomes in vaccinated patients with chronic liver disease and cirrhosis: A national COVID cohort collaborative study","volume":"77","author":"Ge","year":"2023","journal-title":"Hepatology"},{"key":"2025112109554130000_72.9.1783.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.11.015"},{"key":"2025112109554130000_72.9.1783.51","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.4049\/jimmunol.1600818","article-title":"The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray","volume":"197","author":"Cl\u00e0ria","year":"2016","journal-title":"The Journal of Immunology"},{"key":"2025112109554130000_72.9.1783.52","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.062398"},{"key":"2025112109554130000_72.9.1783.53","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000000780","article-title":"Ace2: A linkage for the interplay between COVID-19 and decompensated cirrhosis","volume":"115","author":"Gao","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"2025112109554130000_72.9.1783.54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3"},{"key":"2025112109554130000_72.9.1783.55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.livres.2018.03.003","article-title":"Cytokines and fatty liver diseases","volume":"2","author":"Niederreiter","year":"2018","journal-title":"Liver Research"},{"key":"2025112109554130000_72.9.1783.56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.dld.2020.09.007","article-title":"Metabolic associated fatty liver disease increases the severity of COVID-19: A meta-analysis","volume":"53","author":"Pan","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2025112109554130000_72.9.1783.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.044"},{"key":"2025112109554130000_72.9.1783.58","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.626425","article-title":"Metabolic associated fatty liver disease is associated with an increased risk of severe COVID-19: A systematic review with meta-analysis","volume":"8","author":"Hegyi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2025112109554130000_72.9.1783.59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2022.07.028","article-title":"Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States","volume":"78","author":"Gao","year":"2023","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.60","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-Cov-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J Clin Invest"},{"key":"2025112109554130000_72.9.1783.61","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1665-2681(19)31294-3","article-title":"Pioglitazone Upregulates hepatic angiotensin converting enzyme 2 expression in rats with Steatohepatitis","volume":"12","author":"Zhang","year":"2013","journal-title":"Ann Hepatol"},{"key":"2025112109554130000_72.9.1783.62","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2775-0"},{"key":"2025112109554130000_72.9.1783.63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12250-020-00276-5","article-title":"Clinical characteristics of hospitalized patients with SARS-Cov-2 and hepatitis B virus Co-infection","volume":"35","author":"Chen","year":"2020","journal-title":"Virol Sin"},{"key":"2025112109554130000_72.9.1783.64","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s10620-022-07687-2","article-title":"Effects of hepatitis B virus infection on patients with COVID-19: A meta-analysis","volume":"68","author":"Yu","year":"2023","journal-title":"Dig Dis Sci"},{"key":"2025112109554130000_72.9.1783.65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/liv.14774","article-title":"Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study","volume":"41","author":"Liu","year":"2021","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.66","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/jvh.13362","article-title":"Clinical characteristics in patients with SARS-Cov-2\/HBV Co-infection","volume":"27","author":"Chen","year":"2020","journal-title":"J Viral Hepat"},{"key":"2025112109554130000_72.9.1783.67","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/liv.14804","article-title":"Mortality is not increased in SARS-Cov-2 infected persons with hepatitis C virus infection","volume":"41","author":"Butt","year":"2021","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.68","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality","volume":"9","author":"Ronderos","year":"2021","journal-title":"World J Clin Cases"},{"key":"2025112109554130000_72.9.1783.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104857"},{"key":"2025112109554130000_72.9.1783.70","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27426"},{"key":"2025112109554130000_72.9.1783.71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/ID9.0000000000000007","article-title":"Ace2 and Tmprss2 expression in hepatocytes of chronic HBV infection patients","volume":"1","author":"Hu","year":"2021","journal-title":"Infectious Diseases & Immunity"},{"key":"2025112109554130000_72.9.1783.72","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.725528","article-title":"Host Serine proteases: A potential targeted therapy for COVID-19 and influenza","volume":"8","author":"Rahbar Saadat","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2025112109554130000_72.9.1783.73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.csbj.2020.12.035","article-title":"Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human Serine protease Tmprss2","volume":"19","author":"Zhu","year":"2021","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"2025112109554130000_72.9.1783.74","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/QCO.0b013e328355660b","article-title":"Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host","volume":"25","author":"Kaltsas","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"2025112109554130000_72.9.1783.75","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000786"},{"key":"2025112109554130000_72.9.1783.76","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2021.01.021","article-title":"SARS-Cov-2 infection in patients with autoimmune hepatitis","volume":"74","author":"Marjot","year":"2021","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.77","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep4.1557","article-title":"Coronavirus disease 2019 in autoimmune hepatitis: A lesson from immunosuppressed patients","volume":"4","author":"Gerussi","year":"2020","journal-title":"Hepatol Commun"},{"key":"2025112109554130000_72.9.1783.78","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2020.05.008","article-title":"Health status of patients with autoimmune liver disease during SARS-Cov-2 outbreak in northern Italy","volume":"73","author":"Di Giorgio","year":"2020","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/liv.15121","article-title":"Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis","volume":"42","author":"Efe","year":"2022","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.80","first-page":"741","article-title":"Infectious complications after liver transplantation","volume":"11","author":"Hernandez","year":"2015","journal-title":"Gastroenterol Hepatol"},{"key":"2025112109554130000_72.9.1783.81","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.82","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"key":"2025112109554130000_72.9.1783.83","doi-asserted-by":"crossref","unstructured":"Varghese PM , Kishore U , Rajkumari R . Innate and adaptive immune responses against influenza A virus: immune evasion and vaccination strategies. Immunobiology 2022;227. doi:10.1016\/j.imbio.2022.152279","DOI":"10.1016\/j.imbio.2022.152279"},{"key":"2025112109554130000_72.9.1783.84","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe0240","article-title":"Defining the features and duration of antibody responses to SARS-Cov-2 infection associated with disease severity and outcome","volume":"5","author":"R\u00f6ltgen","year":"2020","journal-title":"Sci Immunol"},{"key":"2025112109554130000_72.9.1783.85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"Bnt162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"2025112109554130000_72.9.1783.86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of Chadox1 nCoV-19 (Azd1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat Med"},{"key":"2025112109554130000_72.9.1783.87","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0897-1"},{"key":"2025112109554130000_72.9.1783.88","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2020.100040","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Rep Med"},{"key":"2025112109554130000_72.9.1783.89","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-Cov-2 vaccination induces immunological T cell memory able to cross-recognize variants from alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"2025112109554130000_72.9.1783.90","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41564-022-01106-y","article-title":"SARS-Cov-2-specific T-cell EPITOPE repertoire in Convalescent and mRNA-vaccinated individuals","volume":"7","author":"Lang-Meli","year":"2022","journal-title":"Nat Microbiol"},{"key":"2025112109554130000_72.9.1783.91","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01122-w"},{"key":"2025112109554130000_72.9.1783.92","doi-asserted-by":"crossref","first-page":"108728","DOI":"10.1016\/j.celrep.2021.108728","article-title":"Early induction of functional SARS-Cov-2-specific T cells Associates with rapid viral clearance and mild disease in COVID-19 patients","volume":"34","author":"Tan","year":"2021","journal-title":"Cell Reports"},{"key":"2025112109554130000_72.9.1783.93","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/s41423-021-00743-3","article-title":"SARS-Cov-2-specific T cells in infection and vaccination","volume":"18","author":"Bertoletti","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2025112109554130000_72.9.1783.94","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-020-01143-2"},{"key":"2025112109554130000_72.9.1783.95","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.32619","article-title":"Comparison of Infection\u2010Induced and Vaccine\u2010Induced immunity against COVID\u201019 in patients with cirrhosis","volume":"77","author":"John","year":"2023","journal-title":"Hepatology"},{"key":"2025112109554130000_72.9.1783.96","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16599"},{"key":"2025112109554130000_72.9.1783.97","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/lt.26389","article-title":"Decreased long-term severe acute respiratory syndrome Coronavirus 2-specific humoral immunity in liver transplantation recipients 12 months after Coronavirus disease 2019","volume":"28","author":"Caballero\u2010Marcos","year":"2022","journal-title":"Liver Transpl"},{"key":"2025112109554130000_72.9.1783.98","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326609"},{"key":"2025112109554130000_72.9.1783.99","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1111\/ajt.16708","article-title":"T cell-mediated response to SARS-Cov-2 in liver transplant recipients with prior COVID-19","volume":"21","author":"Fern\u00e1ndez-Ruiz","year":"2021","journal-title":"American Journal of Transplantation"},{"key":"2025112109554130000_72.9.1783.100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0276929","article-title":"Reduced humoral but stable cellular SARS-Cov-2-specific immunity in liver transplant recipients in the first year after COVID-19","volume":"17","author":"Kirchner","year":"2022","journal-title":"PLoS One"},{"key":"2025112109554130000_72.9.1783.101","doi-asserted-by":"crossref","unstructured":"Citores MJ , Caballero-Marcos A , Cuervas-Mons V , et al . Long term SARS-Cov-2-specific cellular immunity after COVID-19 in liver transplant recipients. J Microbiol Immunol Infect 2023:00071\u20133. doi:10.1016\/j.jmii.2023.03.003","DOI":"10.1016\/j.jmii.2023.03.003"},{"key":"2025112109554130000_72.9.1783.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105098"},{"key":"2025112109554130000_72.9.1783.103","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/liv.15403","article-title":"Immunogenicity of COVID-19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta-analysis","volume":"43","author":"Luo","year":"2023","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.104","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1016\/j.vaccine.2022.10.042","article-title":"Poor immune response to Coronavirus disease vaccines in decompensated cirrhosis patients and liver transplant recipients","volume":"40","author":"Kulkarni","year":"2022","journal-title":"Vaccine"},{"key":"2025112109554130000_72.9.1783.105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2021.09.003","article-title":"SARS-Cov2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","volume":"20","author":"Ruether","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112109554130000_72.9.1783.106","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.dld.2022.09.010","article-title":"Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study","volume":"55","author":"Iavarone","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2025112109554130000_72.9.1783.107","doi-asserted-by":"crossref","unstructured":"Aggeletopoulou I , Davoulou P , Konstantakis C , et al . Response to hepatitis B vaccination in patients with liver cirrhosis. Rev Med Virol 2017;27. doi:10.1002\/rmv.1942","DOI":"10.1002\/rmv.1942"},{"key":"2025112109554130000_72.9.1783.108","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031070","article-title":"Effectiveness of influenza vaccines in adults with chronic liver disease: a systematic review and meta-analysis","volume":"9","author":"H\u00e4rm\u00e4l\u00e4","year":"2019","journal-title":"BMJ Open"},{"key":"2025112109554130000_72.9.1783.109","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2021.08.008","article-title":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","volume":"75","author":"Thuluvath","year":"2021","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.10.006"},{"key":"2025112109554130000_72.9.1783.111","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jhep.2020.10.012","article-title":"IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis","volume":"74","author":"Basho","year":"2021","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.112","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-031210-101400"},{"key":"2025112109554130000_72.9.1783.113","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2022.07.036","article-title":"Third dose of COVID-19 mRNA vaccine appears to overcome vaccine Hyporesponsiveness in patients with cirrhosis","volume":"77","author":"John","year":"2022","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.114","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ueg2.12218","article-title":"SARS-Cov-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease","volume":"10","author":"Duengelhoef","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"2025112109554130000_72.9.1783.115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jhep.2021.04.026","article-title":"Safety and Immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (Chess2101): A multicenter study","volume":"75","author":"Wang","year":"2021","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.116","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3350\/cmh.2022.0082","article-title":"Effect of moderate-to-severe hepatic steatosis on Neutralising antibody response among BNT162b2 and Coronavac recipients","volume":"28","author":"Cheung","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"2025112109554130000_72.9.1783.117","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15173"},{"key":"2025112109554130000_72.9.1783.118","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.759","article-title":"Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-Cov-2 vaccination in patients with chronic hepatitis B virus infection","volume":"11","author":"He","year":"2023","journal-title":"Immun Inflamm Dis"},{"key":"2025112109554130000_72.9.1783.119","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6"},{"key":"2025112109554130000_72.9.1783.120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low Immunogenicity to SARS-Cov-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.121","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/liv.15258","article-title":"Mycophenolate mofetil decreases humoral responses to three doses of SARS-Cov-2 vaccine in liver transplant recipients","volume":"42","author":"Meunier","year":"2022","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.122","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-2600(22)00186-2","article-title":"Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial","volume":"10","author":"Abhishek","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2025112109554130000_72.9.1783.123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100496","article-title":"Impaired SARS-Cov-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination","volume":"4","author":"Al-Dury","year":"2022","journal-title":"JHEP Rep"},{"key":"2025112109554130000_72.9.1783.124","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.cell.2022.03.018","article-title":"Imprinted SARS-Cov-2-specific memory lymphocytes define hybrid immunity","volume":"185","author":"Rodda","year":"2022","journal-title":"Cell"},{"key":"2025112109554130000_72.9.1783.125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10096-015-2558-8","article-title":"Obesity: impact of infections and response to vaccines","volume":"35","author":"Tagliabue","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2025112109554130000_72.9.1783.126","doi-asserted-by":"crossref","first-page":"103768","DOI":"10.1016\/j.ebiom.2021.103768","article-title":"Peripheral immune cells in NAFLD patients: A Spyhole to disease progression","volume":"75","author":"Lin","year":"2022","journal-title":"EBioMedicine"},{"key":"2025112109554130000_72.9.1783.127","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.cgh.2022.06.028","article-title":"Humoral and cellular immune response after third and fourth SARS-Cov-2 mRNA vaccination in liver transplant recipients","volume":"20","author":"Harberts","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025112109554130000_72.9.1783.128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2022.03.042","article-title":"A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients","volume":"77","author":"Davidov","year":"2022","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.129","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2023.02.007","article-title":"Boosting compromised SARS-Cov-2-specific immunity with mRNA vaccination in liver transplant recipients","volume":"78","author":"Luxenburger","year":"2023","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.130","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02717-3\/ATTACHMENT\/B46F0D22-54E3-48A2-A676-52E85F5D4A32\/MMC2.PDF"},{"key":"2025112109554130000_72.9.1783.131","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S1473-3099(22)00271-7","article-title":"Safety, Immunogenicity, and Reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of Chadox1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a Multicentre, blinded, phase 2, randomised trial","volume":"22","author":"Munro","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025112109554130000_72.9.1783.132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/liv.15368","article-title":"Analysis of the humoral and cellular response after the third COVID-19 vaccination in patients with autoimmune hepatitis","volume":"43","author":"Hartl","year":"2023","journal-title":"Liver Int"},{"key":"2025112109554130000_72.9.1783.133","doi-asserted-by":"crossref","first-page":"1035073","DOI":"10.3389\/fimmu.2022.1035073","article-title":"Autoimmune hepatitis after COVID-19 vaccination","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Immunol"},{"key":"2025112109554130000_72.9.1783.134","unstructured":"Mentzer D , Keller-Stanislawski B , Paul-Ehrlich-Institut D . \/\/Verdachtsf\u00e4lle von Nebenwirkungen Oder Impfkomplikati- Onen Nach Impfung MIT DEN Omikron-Adaptierten Bivalenten COVID-19-Impfstoffen Comirnaty original\/Omicron BA.1, Comirnaty original\/Omicron BA.4-5, Spikevax Bivalent\/; 2022. Omicron"},{"key":"2025112109554130000_72.9.1783.135","doi-asserted-by":"crossref","unstructured":"Mann R , Sekhon S , Sekhon S . Drug-induced liver injury after COVID-19 vaccine. Cureus 2021. doi:10.7759\/cureus.16491","DOI":"10.7759\/cureus.16491"},{"key":"2025112109554130000_72.9.1783.136","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.3390\/vaccines10122073","article-title":"Vaccine-related autoimmune hepatitis: emerging association with SARS-Cov-2 vaccination or coincidence","volume":"10","author":"Trontzas","year":"2022","journal-title":"Vaccines"},{"key":"2025112109554130000_72.9.1783.137","doi-asserted-by":"crossref","unstructured":"Alqarni MM , Faloudah AZ , Alsulaihebi AS , et al . A case of hepatotoxicity after receiving a COVID-19 vaccine. Cureus 2021. doi:10.7759\/cureus.20455","DOI":"10.7759\/cureus.20455"},{"key":"2025112109554130000_72.9.1783.138","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.024"},{"key":"2025112109554130000_72.9.1783.139","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-induced liver injury","volume":"139","author":"Fisher","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2025112109554130000_72.9.1783.140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jhep.2022.02.014","article-title":"Unexplained liver test elevations after SARS-Cov-2 vaccination","volume":"77","author":"Guardiola","year":"2022","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.141","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100605","article-title":"Histological and serological features of acute liver injury after SARS-Cov-2 vaccination","volume":"5","author":"Codoni","year":"2023","journal-title":"JHEP Rep"},{"key":"2025112109554130000_72.9.1783.142","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after Coronavirus disease 2019 (COVID-19) vaccine: causality or casualty","volume":"75","author":"Bril","year":"2021","journal-title":"Journal of Hepatology"},{"key":"2025112109554130000_72.9.1783.143","doi-asserted-by":"crossref","first-page":"102706","DOI":"10.1016\/j.jaut.2021.102706","article-title":"Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity","volume":"123","author":"Ghielmetti","year":"2021","journal-title":"J Autoimmun"},{"key":"2025112109554130000_72.9.1783.144","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.jhep.2022.10.026","article-title":"Cases of severe acute liver injury following Inactivated SARS-Cov-2 vaccination","volume":"78","author":"Kulkarni","year":"2023","journal-title":"J Hepatol"},{"key":"2025112109554130000_72.9.1783.145","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.040"},{"key":"2025112109554130000_72.9.1783.146","doi-asserted-by":"crossref","unstructured":"Zafar M , Gordon K , Macken L , et al . n.d. COVID-19 vaccination-induced Cholangiopathy and autoimmune hepatitis: A series of two cases [Cureus;14:e30304]. Cureus doi:10.7759\/cureus.30304","DOI":"10.7759\/cureus.30304"},{"key":"2025112109554130000_72.9.1783.147","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jhep.2022.06.032","article-title":"Risk of acute liver injury following the mRNA (BNT162b2) and Inactivated (Coronavac) COVID-19 vaccines","volume":"77","author":"Wong","year":"2022","journal-title":"J Hepatol"}],"updated-by":[{"DOI":"10.1136\/gutjnl-2023-329623corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000}}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2023-329623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:56:00Z","timestamp":1763747760000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2023-329623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":147,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,8,7]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1136\/gutjnl-2023-329623"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2023-329623","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}